Terry Magnuson was recruited to the University of North Carolina at Chapel Hill in 2000 as founding chair of the Department of Genetics and Director of the newly established Carolina Center for Genome Sciences at the UNC School of Medicine. He also created the Cancer Genetics Program in the UNC Lineberger Comprehensive Cancer Center. He was appointed Vice Dean for Research in the School of Medicine in 2010 and was selected to be the Vice Chancellor for Research for UNC-CH in 2016. A founding member of the International Mammalian Genome Society, Dr. Magnuson also served on the external advisory committee for the Mouse Genome Database at the Jackson Laboratory and was Chair of the Jackson Laboratory Board of Scientific Overseers. He has served on the Board of Directors of the Society for Developmental Biology, and the Genetics Society of America. He was appointed by the National Academies to the committee that wrote guidelines for work with human embryonic stem cells, and also served as vice chair of an Institute of Medicine committee evaluating the California Institute for Regenerative Medicine, and served as a member of the Institute of Medicine’s committee reviewing the NIH Recombinant DNA Advisory Committee as well as serving on the Committee on the State of Science in Ovarian Cancer Research. Currently, he is a member of the NIH stem cell working group, and the NIH Council of Councils. He was elected to the American Academy of Arts and Sciences, a fellow of the AAAS, and to the National Academy of Medicine. He is a Senior Editor for Genetics. The work in the Magnuson lab focuses on the role of mammalian genes in unique epigenetic phenomena such as genomic imprinting, X-chromosome inactivation and stem cell pluripotency. The lab also studies the tumor suppressor role of chromatin remodeling complexes and has developed a novel mouse model for ovarian clear cell carcinoma. Dr. Magnuson received his Ph.D. from Cornell University and was a postdoctoral fellow at UCSF.